Share Price | Accretion Nutraveda Ltd Stock Analysis & Recommendation

Q: Why is Accretion Nutraveda Ltd falling/rising?

As of 18-Jul, Accretion Nutraveda Ltd's stock price is rising, currently at Rs 268.00, which reflects an increase of Rs 6.00 or 2.29%. This rise can be attributed to several factors. Firstly, the stock has outperformed its sector by 3.7% today, indicating strong relative performance. Additionally, it reached an intraday high of Rs 268, confirming the upward movement in price. Moreover, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator suggesting a bullish trend. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 54.55% compared to the 5-day average, which could indicate a potential concern for sustained momentum. Despite this, the overall performance today and the technical indicators support the current rise in the stock price.

Q: What does Accretion Nutrav do?

Overview:Accretion Nutraveda Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.History:Accretion Nutraveda Ltd was incorporated as a Private Limited Company on March 16, 2021, and later converted to a Public Limited Company on May 2, 2025. Revenue and profit data for the latest quarter are not available.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: N/AMarket-cap value: INR 188 Cr (Micro Cap)Key Metrics:P/E: 37.00Industry P/E: 34Dividend Yield: 0.00%Debt-Equity: 0.00Return on Equity: 0.00%Price to Book: 0.00Contact Details:Registrar Address: Not available.

Q: How big is Accretion Nutrav?

As of 10th June, Market Cap: Accretion Nutraveda Ltd has a market capitalization of 188.00 Cr, categorized as a Micro Cap.Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.Balance Sheet Snapshot: There is no valid balance sheet data available for the latest annual period, including values for Shareholder's Funds and Total Assets.

Q: Who are the peers of the Accretion Nutrav?

Peers: The peers of Accretion Nutrav are Kerala Ayurveda, Nectar Lifesci., Syschem (India), Brooks Lab., Oxygenta Pharma, Coral Labs., Sanjiv.Parant., Natural Capsules.Quality Snapshot: Below Average management risk is observed at Kerala Ayurveda, Syschem (India), Brooks Lab., Coral Labs., and Natural Capsules, while Average management risk is found at Nectar Lifesci. Good management risk is noted at Sanjiv.Parant. For growth, Good growth is seen at Syschem (India) and Sanjiv.Parant., while Below Average growth is present at Kerala Ayurveda, Nectar Lifesci., Brooks Lab., Oxygenta Pharma, Coral Labs., and Natural Capsules. In terms of Capital Structure, Excellent capital structure is noted at Coral Labs., while Good capital structure is found at Syschem (India) and Sanjiv.Parant., with Below Average capital structure at the rest.Return Snapshot: The peer with the highest 1-year return is Guj. Inject(Ker) at 427.17%, while the peer with the lowest 1-year return is Kerala Ayurveda at -64.41%. Accretion Nutrav's 1-year return is not available for comparison. Additionally, several peers, including Oxygenta Pharma, Sanjiv.Parant., and Natural Capsules, have negative six-month returns.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.0 k (-58.33%) Volume

Shareholding (Mar 2026)

FII

1.08%

Held by 1 FIIs

DII

7.00%

Held by 0 DIIs

Promoter

73.48%

Why is Accretion Nutraveda Ltd falling/rising?

19-Jul-2026

As of 18-Jul, Accretion Nutraveda Ltd's stock price is at Rs 268.00, reflecting a 2.29% increase. The stock is outperforming its sector and trading above key moving averages, indicating a bullish trend, although a decline in investor participation may raise concerns about sustained momentum.

View full answer

Which are the latest news on Accretion Nutrav?

18-Jul-2026

When is the next results date for Accretion Nutraveda Ltd?

What does Accretion Nutrav do?

11-Jun-2026

Accretion Nutraveda Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2021 and converted to a Public Limited Company in 2025. It currently has no available revenue or profit data, with a market cap of INR 188 Cr and a P/E ratio of 37.00.

View full answer

How big is Accretion Nutrav?

11-Jun-2026

As of 10th June, Accretion Nutraveda Ltd has a market capitalization of 188.00 Cr, categorized as a Micro Cap. There is no valid financial data available for net sales, net profit, or balance sheet metrics for the latest periods.

View full answer

Who are the peers of the Accretion Nutrav?

11-Jun-2026

Accretion Nutrav's peers include Kerala Ayurveda, Nectar Lifesci., Syschem (India), Brooks Lab., Oxygenta Pharma, Coral Labs., Sanjiv.Parant., and Natural Capsules. Management risks vary, with good ratings for Sanjiv.Parant. and Syschem (India), while 1-year returns range from -64.41% for Kerala Ayurveda to 427.17% for Guj. Inject(Ker).

View full answer

When is the next results date for Accretion Nutraveda Ltd?

05-May-2026

The next results date for Accretion Nutraveda Ltd is 08 May 2026.

View full answer

Compare Accretion Nutrav with Similar Stocks

Guj. Inject(Ker)Oxygenta Pharma Syschem (India)

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 187 Cr (Micro Cap)

P/E

38.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

36.01%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Accretion Nutrav for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Accretion Nutraveda Ltd?

The next results date for Accretion Nutraveda Ltd is scheduled for 08 May 2026....

Read full news article

Announcements

Announcement Under Regulation 30 Of SEBI (LODR)- Award

09-Jul-2026 | Source : BSE

Please find enclosed herewith Global Export Excellence Award at the Leaders of Navbharat Award & Conclave organized by Times Now Group.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Jul-2026 | Source : BSE

Please find enclosed herewith intimation under regulation 74(5) of SEBI (DP) regulations 2018

Announcement under Regulation 30 (LODR)-Press Release / Media Release

15-May-2026 | Source : BSE

Accretion Nutraveda Limited has informed the Exchange regarding Press Release dated 15th May 2026 titled Company Delivers Robust Performance in H2 FY26 : Revenue up 80.09% YOY and EBITDA up 42.64% and growth Driven by strong demand Operational Expansion and Expanding Market Presence.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

3.70

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

18.36%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.08%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

29.27

EV to EBITDA

28.16

EV to Capital Employed

EV to Sales

5.77

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bearish

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (1.08%)

Promoter with highest holding

Ankurkumar Shantilal Patel (14.7%)

Highest Public shareholder

Unicorn Fund (6.59%)

Individual Investors Holdings

14.19%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Accretion Nutrav"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.54",
          "val2": "14.06",
          "chgp": "38.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.56",
          "val2": "3.29",
          "chgp": "8.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.26",
          "chgp": "3.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.69",
          "val2": "2.33",
          "chgp": "15.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.22%",
          "val2": "23.40%",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Accretion Nutrav"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.60",
          "val2": "16.00",
          "chgp": "110.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.89",
          "val2": "3.72",
          "chgp": "85.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "0.35",
          "chgp": "51.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.07",
          "val2": "2.50",
          "chgp": "102.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.51%",
          "val2": "23.25%",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

19.54

14.06

38.98%

Operating Profit (PBDIT) excl Other Income

3.56

3.29

8.21%

Interest

0.27

0.26

3.85%

Exceptional Items

0.00

Standalone Net Profit

2.69

2.33

15.45%

Operating Profit Margin (Excl OI)

18.22%

23.40%

-5.18%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025

Standalone Net Profit

Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025

All Half Yearly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

33.60

16.00

110.00%

Operating Profit (PBDIT) excl Other Income

6.89

3.72

85.22%

Interest

0.53

0.35

51.43%

Exceptional Items

0.00

Standalone Net Profit

5.07

2.50

102.80%

Operating Profit Margin (Excl OI)

20.51%

23.25%

-2.74%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025

All Annual Results

Company CV

About Accretion Nutraveda Ltd

Accretion Nutraveda Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.

Company Coordinates

No Company Details Available